Benzodiazepines in epilepsy: pharmacology and pharmacokinetics

@article{Riss2008BenzodiazepinesIE,
  title={Benzodiazepines in epilepsy: pharmacology and pharmacokinetics},
  author={J. Riss and J. Cloyd and J. Gates and S. Collins},
  journal={Acta Neurologica Scandinavica},
  year={2008},
  volume={118}
}
  • J. Riss, J. Cloyd, +1 author S. Collins
  • Published 2008
  • Medicine
  • Acta Neurologica Scandinavica
    • Benzodiazepines (BZDs) remain important agents in the management of epilepsy. They are drugs of first choice for status epilepticus and seizures associated with post‐anoxic insult and are also frequently used in the treatment of febrile, acute repetitive and alcohol withdrawal seizures. Clinical advantages of these drugs include rapid onset of action, high efficacy rates and minimal toxicity. Benzodiazepines are used in a variety of clinical situations because they have a broad spectrum of… CONTINUE READING
    View on Wiley
    onlinelibrary.wiley.com
    368 Citations
    Highly Influencial Citations
    20
    Background Citations
    155
    Methods Citations
    9
    Results Citations
    2
    368 Citations
    Citation Type

    Citation Type

    Clinically Significant Interactions with Benzodiazepines
    • 1
    Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam
    • 5
    • PDF
    Single dose efficacy evaluation of two partial benzodiazepine receptor agonists in photosensitive epilepsy patients: A placebo-controlled pilot study
    • 11
    Antiepileptic drugs
    Benzodiazepines for prolonged seizures
    • M. Anderson
    • Medicine
    • Archives of Disease in Childhood: Education & Practice Edition
    • 2010
    • 23
    Steering the pharmacological treatment along different metabolic pathways in response to outlying complicated benzodiazepine withdrawal – a case study
    • PDF
    Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage.
    • 27
    Levetiracetam: a review of its use in epilepsy.
    • 136
    Development of subtype-selective GABAA receptor compounds for the treatment of anxiety, sleep disorders and epilepsy
    • 16
    • PDF
    Update on pharmacotherapy of myoclonic seizures
    • 8

    References

    SHOWING 1-10 OF 243 REFERENCES
    Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology.
    • J. Nelson, G. Chouinard
    • Medicine
    • The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique
    • 1999
    • 84
    • Highly Influential
    Pharmacokinetic Optimisation of Benzodiazepine Therapy for Acute Seizures
    • 87
    • Highly Influential
    Benzodiazepines in the treatment of epilepsy in people with intellectual disability.
    • 20
    Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    • G. Chouinard
    • Psychology, Medicine
    • The Journal of clinical psychiatry
    • 2004
    • 254
    Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes.
    • 59
    Guidelines for the rational use of benzodiazepines. When and what to use.
    • 161
    Pharmacokinetics of benzodiazepines. Short-acting versus long-acting.
    • 47
    • Highly Influential
    Benzodiazepines: some aspects of their clinical pharmacology.
    • 13
    The Use of Clobazam, Midazolam, and Nitrazepam in Epilepsy
    • 24
    The Importance of Drug Interactions in Epilepsy Therapy
    • 385
    • PDF